AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06348368 — intervention group
Intervention type: OTHER
Intervention: Pentacam and autorefractometry
Description: Pentacam to detect corneal topographic changes. Auto-refractometry to assess refraction condition of the children
Study NCT04850157 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: 200mg, Q3W
Study NCT04850157 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: IMRT
Description: 4 Gy\* 5 Fx,5Fx/Week
Study NCT05372822 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Burst Spinal Cord Stimulation
Description: Burst stimulation utilizes complex programming to deliver high-frequency stimuli of a 40 Hz burst mode with 5 spikes at 500 Hz per spike delivered in a constant current mode
Study NCT05372822 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Burst Spinal Cord Stimulation
Description: Burst stimulation utilizes complex programming to deliver high-frequency stimuli of a 40 Hz burst mode with 5 spikes at 500 Hz per spike delivered in a constant current mode
Study NCT05372822 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sham spinal cord stimulation
Description: No spinal cord stimulation is provided
Study NCT05372822 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham spinal cord stimulation
Description: No spinal cord stimulation is provided
Study NCT05372822 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SCS implant
Description: a subcutaneously implantable pulse generator (pacemaker) for long-term therapy.~The following system from Abbott will be implanted: ProclaimTM XR implantable pulse generator and Octrode® 8-contact lead
Study NCT05372822 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SCS implant
Description: a subcutaneously implantable pulse generator (pacemaker) for long-term therapy.~The following system from Abbott will be implanted: ProclaimTM XR implantable pulse generator and Octrode® 8-contact lead
Study NCT04833322 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: D-Galactose
Description: Galactose supplementation, once per day, up to 1.5g/kg per day
Study NCT04532372 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive standard of care drugs
Study NCT04532372 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Best Practice
Description: Receive standard of care drugs
Study NCT04532372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leflunomide
Description: Given PO
Study NCT04532372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Administration
Description: Given PO
Study NCT04532372 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Given PO
Study NCT05879913 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Coronary CT Angiography (CCTA)
Description: Coronary computed tomographic angiography (CCTA) scan is a highly accurate noninvasive technique for detection of coronary artery plaque.
Study NCT04994327 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beta-glucan bread
Description: Frozen bread is administered to the participants for home storage. Bread is thawed at home before consumption. Dosage: At least 3 slices of bread 6 days per week for 16 weeks
Study NCT04994327 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Beta-glucan bread
Description: Frozen bread is administered to the participants for home storage. Bread is thawed at home before consumption. Dosage: At least 3 slices of bread 6 days per week for 16 weeks
Study NCT04897451 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: EQ5D-5L questionnaire self-reported 3 months after delivery
Study NCT04769453 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Canaloplasty using the iTrack microcatheter with Healon GV Pro
Description: 360 degree microcatheterization and viscodilation of Schlemm's canal
Study NCT04769453 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Canaloplasty using the Omni surgical system with Healon GV Pro
Description: 360 degree microcatheterization and viscodilation of Schlemm's canal
Study NCT04769453 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Canaloplasty using the iTrack microcatheter with Healon Pro
Description: 360 degree microcatheterization and viscodilation of Schlemm's canal
Study NCT04769453 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Canaloplasty using the Omni surgical system with Healon Pro
Description: 360 degree microcatheterization and viscodilation of Schlemm's canal
Study NCT04709380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus Toripalimab
Description: Intensity modulated radiotherapy has shown important role in the treatment of hepatocellular carcinoma (HCC), especially for advanced disease with portal vein tumor thrombosis (PVTT), or hepatic vein tumor thrombosis. Toripalimab is a recombinant, humanized programmed death receptor-1 (PD-1) monoclonal antibody that binds to PD-1 and prevents binding of PD-1 with programmed death ligands 1 (PD-L1) and 2 (PD-L2).
Study NCT04709380 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sorafenib
Description: Sorafenib is a multi-targeted oral drug for the treatment of cancer.Treatment of inoperable advanced renal cell carcinoma ,inoperable or distant metastatic primary hepatocellular carcinoma and so on.
Study NCT04604678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Metformin at 1500 mg/day
Study NCT04604678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone
Description: Naltrexone at 4.5 mg/day (LDN)
Study NCT00533741 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide
Description: Adjuvant; administered with SARS-CoV vaccine.
Study NCT00533741 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Saline for injection.
Study NCT00533741 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV
Description: Whole-virus vaccine, grown in certified Vero cells and doubly inactivated by treatment with formalin and ultraviolet light (UV). Supplied in liquid formulation in single dose vials with and without aluminum hydroxide as an adjuvant. Doses supplied without aluminum hydroxide will be 2.5, 5.0 and 10.0 mcg. Doses supplied with aluminum hydroxide adjuvant will be 2.5 and 5.0 mcg.
Study NCT04390750 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Care Partner-Assisted Intervention
Description: Tailored teaching and coaching
Study NCT05135949 — intervention group
Intervention type: OTHER
Intervention: Patient Reported Outcomes
Description: Satisfaction, Disabilities of the Shoulder, Arm and Hand
Study NCT05135949 — intervention group
Intervention type: OTHER
Intervention: Strength Test
Description: Handheld dynamometer to measure tricep extension
Study NCT05779397 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Masimo RAD-GT
Description: Non-contact infrared thermometry device
Study NCT04903808 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allium Sativum Oil
Description: Garlic oil Captain Company (CAP-PHARM)
Study NCT04903808 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mineral Tri-Oxide Aggregate
Description: ProRoot MTA, Dentsply
Study NCT06151145 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Participants in usual care will be emailed monthly educational modules with information on maintaining weight loss.
Study NCT06151145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SELF
Description: The SELF group will receive a wireless smart body weight scale and wearable physical activity tracker, and text messages.
Study NCT06151145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STEP
Description: The STEP intervention consists of 4 steps that are progressive and based on response to treatment. Step 1: Digital health intervention. The first step will be the digital health intervention as described under SELF. Step 2: Monthly, in-person counseling. Participants who move to Step 2 will be provided with monthly, in-person counseling. Step 3: Twice per month counseling. Step 3 will be twice-monthly counseling, spaced at every other week. Step 4: Meal replacements. Participants will be prescribed a partial meal replacement program.
Study NCT06225635 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ezerosu(monolayer tablet)
Description: Ezetimibe 10mg, Rosuvastatin calcium 20.8mg(20mg as Rosuvastatin)
Study NCT06225635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ezerosu(monolayer tablet)
Description: Ezetimibe 10mg, Rosuvastatin calcium 20.8mg(20mg as Rosuvastatin)
Study NCT06225635 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ezerosu(double layer tablet)
Description: Ezetimibe 10mg, Rosuvastatin calcium 20.8mg(20mg as Rosuvastatin)
Study NCT06225635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ezerosu(double layer tablet)
Description: Ezetimibe 10mg, Rosuvastatin calcium 20.8mg(20mg as Rosuvastatin)
Study NCT06270433 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toludesvenlafaxine hydrochloride sustained-release tablets
Description: 80 mg or 120 mg or 160 mg orally once daily dosing for 8 weeks
Study NCT06270433 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Desvenlafaxine succinate sustained-release tablets
Description: 50 mg orally once daily dosing for 8 weeks
Study NCT05280587 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Technological Rehabilitation
Description: Specific rehabilitation for balance disorder using the robotic platform
Study NCT05898386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behaviour and Lifestyle Changes in Urinary Incontinence
Description: The women included in the second stage were given a pre-test before the training program. Training program included behavioral and lifestyle changes in coping with urinary incontinence~After the training program, the women applied behavior and lifestyle changes for 3 months.~3 home visits, 3 phone calls and 3 follow-ups were made.
Study NCT06147635 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Micro-encapsulated granules of tributyrin (intervention)
Description: Three times daily 4 grams of micro-encapsulated granules of tributyrin, for a maximum of 14 days
Study NCT06147635 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Micro-encapsulated granules of sunflower oil (placebo)
Description: Three times daily 4 grams of micro-encapsulated granules of sunflower oil, for a maximum of 14 days
Study NCT04680403 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: supervised exercise paired with coaching on behavior change techniques over 12 weeks (3 weekly sessions) and will have monthly phone follow-ups and clinic follow-ups after 3 and 6 months.
Study NCT05092633 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Miniscrew
Description: Application of laser on miniscrew
Study NCT04841551 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Kybella Flanks
Description: 10 subjects will be treated with Kybella in the flanks
Study NCT04081454 — intervention group
Intervention type: BEHAVIORAL
Intervention: Workshop
Description: one-day (6 hour) program to help children and their parents or caregivers learn how to better manage chronic pain
Study NCT05365425 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Policosanol
Description: policosanol 10mg
Study NCT04081454 — intervention group
Intervention type: BEHAVIORAL
Intervention: Education
Description: The parent program includes psychoeducation regarding pain in the context of adolescent development, didactic and vignette-based practice of an adaptive parent communication response style (i.e., reflective listening), and concrete tools for setting up behavior plans to scaffold an adolescent's return to function for school, sleep, daily activities, and exercise. All parents are provided with a take-home workbook inclusive of neuroscience and psychoeducational materials as well as a list of resources to further solidify the information they learned.
Study NCT06493812 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fascia lata
Description: This intervention involves the harvesting of fascia lata from the thigh and its use in reconstructing the skull base defect following endoscopic endonasal surgery for sellar region pathology. The graft is extracted from the left thigh, and standard reconstruction techniques are employed to ensure optimal healing and functionality of the skull base. Postoperative monitoring includes assessments of donor site pain, incidence of complications, and overall recovery using standardized measures.
Study NCT06493812 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Temporal fascia
Description: This intervention involves the harvesting of temporal muscle fascia from the temporal region of the head and its use in reconstructing the skull base defect following endoscopic endonasal surgery for sellar region pathology. The graft is extracted from the left temporal region, and standard reconstruction techniques are employed to ensure optimal healing and functionality of the skull base. Postoperative monitoring includes assessments of donor site pain, incidence of complications, and overall recovery using standardized measures.
Study NCT04065152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Talimogene laherparepvec
Description: Talimogene laherparepvec
Study NCT05604833 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Exercises
Description: In the research, data will be collected with the Descriptive Information Form and Pittsburgh Sleep Quality Index (PUKI). Statistical analysis of the data obtained as a result of the research will be made in the IBM SPSS25 program. This study was planned because it is thought that making progressive muscle relaxation exercises (PKGE) in patients with poor sleep quality who receive hemodialysis treatment will be effective in increasing sleep quality, since it is easy to learn, can be done anywhere, and has no side effects.
Study NCT04987658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OLZ/SAM
Description: Olanzapine and Samidorphan taken once daily over a max period of 21 days
Study NCT06348940 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: behavioral activation
Description: Behavioral activation, an emerging psychological intervention approach, has potential in alleviating negative emotions among cancer patients. The intervention group underwent an eight-week behavioral activation program designed to promote engagement in meaningful activities that are physically and emotionally rewarding while reducing involvement in maladaptive emotional cycles.
Study NCT05390359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-intensity and short-duration
Description: The ultrasound guided percutaneous electrolysis will be applied in the middle of the patellar tendon.~The parameters will be 3 squared pulses of a high intensity current (3 mA), that will be applied for 3 seconds with 3 seconds rests between pulses and 1 second of pulses ramp.~The current will be off on the first 348 seconds of the intervention approximately and the last 18 seconds it will be on. The total treatment time will be 366 seconds.
Study NCT05390359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-intensity and long-duration
Description: The ultrasound guided percutaneous electrolysis will be applied in the middle of the patellar tendon.~The parameters will be 3 squared pulses of a low intensity direct current (0.1 mA) during 90 seconds, with 3 seconds rests between pulses and 1 second of pulses ramp.~The total treatment time will be 366 seconds.
Study NCT05390359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-intensity, short-duration and 20 Hz
Description: The ultrasound guided percutaneous electrolysis will be applied in the middle of the patellar tendon.~The parameters will be 3 pulses of a high intensity compensated biphasic current (3 mA), during 3 seconds with 3 seconds rests between pulses and 1 second of pulses ramp. The alternating frequency will be of 20 Hz and the pulse width of 50 microseconds.~The current will be off on the first 348 seconds of the intervention approximately and the last 18 seconds it will be on. The total treatment time will be 366 seconds.
Study NCT05390359 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham electrolysis
Description: The control ultrasound guided percutaneous electrolysis will be applied in the middle of the patellar tendon, without electrical stimulation during 366 seconds.
Study NCT05439434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fear of Pain Questionnaire for Children Short Form
Description: administering the questionnaire twice, one week apart.
Study NCT06027190 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation
Description: Intervention Name and Specification~1. Transcranial magnetic stimulator (M-100 Ultimate, Yingzhi Technology Co., Ltd., China) .~2. 70-mm-diameter figure-of-eight coil (BY90A, Yingzhi Technology Co., Ltd., China). 3) Placebo coil (Magstim Company, Whitland, UK): the appearance and sound were consistent with the true coil, but no current stimulation was produced.
Study NCT06027190 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Placebo coil (Magstim Company, Whitland, UK):
Study NCT06510647 — intervention group
Intervention type: OTHER
Intervention: Hormonal Therapy Agent
Description: With an endometriosis diagnosis in which hormonal therapy is indicated, patients who satisfy inclusion and exclusion criteria will be administered scientifically validated questionnaires at the time of the visit (time 0): Endometriosis Health Profile-30 and the Short Form Health Survey SF-12.~The second evaluation will be conducted 6 months later (time 1) along with a gynecological examination and gynecological ultrasound, and the same two questionnaires will be administered. Patients will be defined as non-responsive to medical therapy if their Endometriosis Health Profile 30 scores are equal to or higher at the time 1 visit compared to the enrollment visit at time 0.~Patients will then be re-evaluated 12 months (time 2) after the first visit with the same criteria, and the two questionnaires will be administered once more. Similarly, patients with EHP-30 scores equal to or higher than the previous control at time 1 will be defined as non-responsive to medical therapy.
Study NCT05964803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaires
Description: MLWH and control groups were asked to complete the following questionnaires: International Consultation on Incontinence Questionnaire - Male Lower Urinary Tract Symptoms (ICIQ-MLUTS), ICIQ-Short Form (ICIQ-SF), International Prostate Symptom Score (IPSS), King's Healthcare Questionnaire (KHQ), 8-item Overactive Bladder Questionnaire (OAB-V8), Urogenital Distress Inventory 6 and 7 (UDI 6 and UDI 7).
Study NCT06428136 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Clamshell exercises with Electrical Muscle Stimulation (CT + EMS)
Description: Side-lying clamshells: 3 sets of 10 repetitions per leg, 3 times per week Hip abduction with theraband: 3 sets of 10 repetitions per leg, 3 times per week Bridge with hip abduction: 3 sets of 10 repetitions per leg, 3 times per week~Electrical muscle stimulation:~Applied to the gluteus medius and minimus muscles for 20 minutes per session, 3 times per week Frequency and intensity adjusted to individual tolerance
Study NCT06428136 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conservative Treatment (CT)
Description: Stretching: Iliotibial band stretch: 30-second hold, 3 repetitions per leg, 2 times per day Quadriceps stretch: 30-second hold, 3 repetitions per leg, 2 times per day Hamstring stretch: 30-second hold, 3 repetitions per leg, 2 times per day
Study NCT06270927 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: neuroimaging using MRI scanner
Study NCT06270927 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CT
Description: neuroimaging using CT scanner
Study NCT05908604 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Robot for madication management
Description: The effect of a robot in medication management for older people's home care
Study NCT05908604 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Robot for madication management
Description: The effect of a robot in medication management for older people's home care
Study NCT05010187 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral: Motivational Interview (MI)
Description: Single-session, brief motivational interview.
Study NCT05010187 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral: Health Coaching (HC)
Description: Single-session health coaching.
Study NCT05572268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
Description: to evaluate the safety and efficacy of Cranmax for the treatment of UTi and control of Ecoli infection
Study NCT05572268 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
Description: to evaluate the safety and efficacy of Cranmax for the treatment of UTi and control of Ecoli infection
Study NCT05755074 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ablation through left arm
Description: Ablation through left arm
Study NCT05755074 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ablation through femoral vein
Description: Ablation through femoral vein